Logo image of IMAC

IMAC HOLDINGS INC (IMAC) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:IMAC - US44967K1043 - Common Stock

1.01 USD
+0.02 (+2%)
Last: 8/5/2022, 8:25:24 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to IMAC. IMAC was compared to 100 industry peers in the Health Care Providers & Services industry. IMAC may be in some trouble as it scores bad on both profitability and health. IMAC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year IMAC has reported negative net income.
IMAC Yearly Net Income VS EBIT VS OCF VS FCFIMAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 -2M -4M -6M -8M -10M

1.2 Ratios

Industry RankSector Rank
ROA -48.41%
ROE N/A
ROIC -45.82%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IMAC Yearly ROA, ROE, ROICIMAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 50 -50 100

1.3 Margins

Industry RankSector Rank
OM -72.27%
PM (TTM) -76.98%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IMAC Yearly Profit, Operating, Gross MarginsIMAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 -500 -1K -1.5K

More info and screens

2

2. Health

2.1 Basic Checks

IMAC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, IMAC has more shares outstanding
Compared to 1 year ago, IMAC has an improved debt to assets ratio.
IMAC Yearly Shares OutstandingIMAC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M 25M
IMAC Yearly Total Debt VS Total AssetsIMAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M 25M

2.2 Solvency

IMAC has an Altman-Z score of -0.90. This is a bad value and indicates that IMAC is not financially healthy and even has some risk of bankruptcy.
IMAC has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -0.9
ROIC/WACC-5.63
WACC8.14%
IMAC Yearly LT Debt VS Equity VS FCFIMAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 5M -5M 10M 15M

2.3 Liquidity

A Current Ratio of 1.27 indicates that IMAC should not have too much problems paying its short term obligations.
A Quick Ratio of 1.27 indicates that IMAC should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.27
IMAC Yearly Current Assets VS Current LiabilitesIMAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2M 4M 6M 8M 10M

More info and screens

6

3. Growth

3.1 Past

IMAC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.64%, which is quite good.
IMAC shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.05%.
The Revenue has been growing by 272.72% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)13.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
Revenue 1Y (TTM)21.05%
Revenue growth 3Y29.01%
Revenue growth 5Y272.72%
Sales Q2Q%27.29%

3.2 Future

The Earnings Per Share is expected to grow by 2.32% on average over the next years.
Based on estimates for the next years, IMAC will show a very strong growth in Revenue. The Revenue will grow by 22.61% on average per year.
EPS Next Y2.98%
EPS Next 2Y7.43%
EPS Next 3Y4.29%
EPS Next 5Y2.32%
Revenue Next Year21.45%
Revenue Next 2Y23.21%
Revenue Next 3Y22.4%
Revenue Next 5Y22.61%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
IMAC Yearly Revenue VS EstimatesIMAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
IMAC Yearly EPS VS EstimatesIMAC Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 -0.2 -0.4 -0.6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IMAC. In the last year negative earnings were reported.
Also next year IMAC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IMAC Price Earnings VS Forward Price EarningsIMAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -2.44
IMAC Per share dataIMAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.43%
EPS Next 3Y4.29%

More info and screens

0

5. Dividend

5.1 Amount

IMAC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IMAC HOLDINGS INC

NASDAQ:IMAC (8/5/2022, 8:25:24 PM)

1.01

+0.02 (+2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-12 2022-05-12/amc
Earnings (Next)08-23 2022-08-23/bmo
Inst Owners11.86%
Inst Owner Change-2.36%
Ins Owners8.88%
Ins Owner Change0%
Market Cap26.75M
Revenue(TTM)15.22M
Net Income(TTM)-11.71M
Analysts80
Price Target3.59 (255.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.76
P/FCF N/A
P/OCF N/A
P/B 1.79
P/tB N/A
EV/EBITDA -2.44
EPS(TTM)-0.38
EYN/A
EPS(NY)-0.35
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.57
BVpS0.57
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -48.41%
ROE N/A
ROCE N/A
ROIC -45.82%
ROICexc N/A
ROICexgc -99.32%
OM -72.27%
PM (TTM) -76.98%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.27
Altman-Z -0.9
F-Score4
WACC8.14%
ROIC/WACC-5.63
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
EPS Next Y2.98%
EPS Next 2Y7.43%
EPS Next 3Y4.29%
EPS Next 5Y2.32%
Revenue 1Y (TTM)21.05%
Revenue growth 3Y29.01%
Revenue growth 5Y272.72%
Sales Q2Q%27.29%
Revenue Next Year21.45%
Revenue Next 2Y23.21%
Revenue Next 3Y22.4%
Revenue Next 5Y22.61%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

IMAC HOLDINGS INC / IMAC FAQ

What is the ChartMill fundamental rating of IMAC HOLDINGS INC (IMAC) stock?

ChartMill assigns a fundamental rating of 3 / 10 to IMAC.


What is the valuation status of IMAC HOLDINGS INC (IMAC) stock?

ChartMill assigns a valuation rating of 2 / 10 to IMAC HOLDINGS INC (IMAC). This can be considered as Overvalued.


What is the profitability of IMAC stock?

IMAC HOLDINGS INC (IMAC) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for IMAC stock?

The Earnings per Share (EPS) of IMAC HOLDINGS INC (IMAC) is expected to grow by 2.98% in the next year.